茵栀黄口服液辅助治疗新生儿母乳性黄疸的临床观察

摘要

目的:观察茵栀黄口服液辅助治疗新生儿母乳性黄疸的疗效和安全性.方法:112例母乳性黄疸新生儿随机均分为对照组和观察组.对照组患儿均停止母乳喂养3 d,采用人工喂养,给予保暖、营养支持、维持水电解质及酸碱平衡、蓝光照射等常规治疗,严重者给予保肝、酶诱导剂等药物治疗;观察组患儿在对照组治疗的基础上给予茵栀黄口服液10 ml,每日2次.两组患儿疗程均为7 d.观察两组患儿的临床疗效,治疗前后血清总胆红素(TBIL)水平及不良反应发生情况.结果:观察组患儿总有效率显著高于对照组,差异有统计学意义(P0.05).结论:在常规治疗的基础上,茵栀黄口服液辅助治疗母乳性新生儿黄疸的疗效较好,且安全性较好.%OBJECTIVE:To observe the clinical efficacy and safety of Yinzhihuang oral liquid in the adjuvant treatment of neo-natal breast-feeding faundice. METHODS:112 newborns with faundice were randomly divided into control group and observation group. Control group stopped breast-feeding for 3 d and given artificial feeding,as well as keeping warm,nutritional support, maintaining water and electrolyte and acid-base balance,blue light irradiation and severe patients were given liver protection,en-zyme inducers;observation group was additionally given Yinzhihuang oral liquid 10 ml,twice a day. The treatment course was 7 d. Clinical efficacy,and serum total bilirubin(TBIL)level before and after treatment,and incidence of adverse reactions in 2 groups were observed. RESULTS:The total effective rate in observation group was significantly higher than control group,the difference was statistically significant(P0.05). CONCLUSIONS:Based on the conventional treatment,Yinzhihuang oral liquid can be used in the adjuvant treatment of neonatal breast-feeding faundice,with good efficacy and good safety.